Literature DB >> 11564625

Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects.

A Geusau1, K Abraham, K Geissler, M O Sator, G Stingl, E Tschachler.   

Abstract

A variety of health effects have been attributed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), but little information is available on the course of a verified high-level TCDD intoxication. In this paper we describe two cases of heavy intoxication with TCDD and present a 2-year follow-up including clinical, biochemical, hematologic, endocrine, and immunologic parameters monitored in two women, 30 and 27 years of age, who suffered from chloracne due to TCDD intoxication of unknown origin. Patient 1, who had the highest TCDD level ever recorded in an individual (144,000 pg/g blood fat), developed severe generalized chloracne, whereas in the second patient, despite heavy intoxication (26,000 pg/g blood fat), only mild facial acne lesions occurred. Both patients initially experienced nonspecific gastrointestinal symptoms. In Patient 1 we observed a moderate elevation of blood lipids, leukocytosis, anemia, and secondary amenorrhoea. The laboratory parameters in Patient 2 were all normal. Despite the high TCDD levels, apart from chloracne, only few clinical and biochemical health effects were observed within the first 2 years after TCDD intoxication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564625      PMCID: PMC1240417          DOI: 10.1289/ehp.01109865

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  21 in total

1.  Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  A Geusau; E Tschachler; M Meixner; S Sandermann; O Päpke; C Wolf; E Valic; G Stingl; M McLachlan
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

Review 2.  A risk-benefit assessment of sulpiride in the treatment of schizophrenia.

Authors:  M C Mauri; S Bravin; A Bitetto; R Rudelli; G Invernizzi
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 3.  The Seveso studies on early and long-term effects of dioxin exposure: a review.

Authors:  P A Bertazzi; I Bernucci; G Brambilla; D Consonni; A C Pesatori
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

4.  Assessment of past occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using blood lipid analyses.

Authors:  M G Ott; P Messerer; A Zober
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

5.  Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident.

Authors:  A Zober; M G Ott; P Messerer
Journal:  Occup Environ Med       Date:  1994-07       Impact factor: 4.402

6.  Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD.

Authors:  M G Ott; A Zober; C Germann
Journal:  Chemosphere       Date:  1994 Nov-Dec       Impact factor: 7.086

Review 7.  A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update.

Authors:  M P Holsapple; N K Snyder; S C Wood; D L Morris
Journal:  Toxicology       Date:  1991       Impact factor: 4.221

View more
  22 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 2.  Advances in analytical techniques for polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like PCBs.

Authors:  Eric J Reiner; Ray E Clement; Allan B Okey; Chris H Marvin
Journal:  Anal Bioanal Chem       Date:  2006-06-23       Impact factor: 4.142

Review 3.  Dioxins: diagnostic and prognostic challenges arising from complex mechanisms.

Authors:  Noel M Rysavy; Kristina Maaetoft-Udsen; Helen Turner
Journal:  J Appl Toxicol       Date:  2012-05-19       Impact factor: 3.446

Review 4.  An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology.

Authors:  Sally S White; Linda S Birnbaum
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2009-10       Impact factor: 3.781

5.  Dioxin-like PCB 126 Increases Systemic Inflammation and Accelerates Atherosclerosis in Lean LDL Receptor-Deficient Mice.

Authors:  Michael C Petriello; J Anthony Brandon; Jessie Hoffman; Chunyan Wang; Himi Tripathi; Ahmed Abdel-Latif; Xiang Ye; Xiangan Li; Liping Yang; Eun Lee; Sony Soman; Jazmyne Barney; Banrida Wahlang; Bernhard Hennig; Andrew J Morris
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

6.  Temporal and anatomical sensitivities to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin leading to premature acyclicity with age in rats.

Authors:  O Jablonska; Z Shi; K E Valdez; A Y Ting; B K Petroff
Journal:  Int J Androl       Date:  2010-01-04

7.  Effect of chronic exposure to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats on ovarian gene expression.

Authors:  Kelli E Valdez; Zhanquan Shi; Alison Y Ting; Brian K Petroff
Journal:  Reprod Toxicol       Date:  2009-03-25       Impact factor: 3.143

Review 8.  A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF.

Authors:  Katsuhiko Yoshizawa; Allison Heatherly; David E Malarkey; Nigel J Walker; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2007-12       Impact factor: 1.902

Review 9.  Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?

Authors:  S Ray; H I Swanson
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

10.  Dioxin cancer risk--example of hormesis?

Authors:  Jouko Tuomisto; Juha Pekkanen; Hannu Kiviranta; Erkki Tukiainen; Terttu Vartiainen; Matti Viluksela; Jouni T Tuomisto
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.